List of Excipients in API loteprednol etabonate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing loteprednol etabonate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | BENZALKONIUM CHLORIDE | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | EDETATE DISODIUM | |
| STAT Rx USA LLC | ALREX | loteprednol etabonate | 16590-007 | GLYCERIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing loteprednol etabonate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 | BENZALKONIUM CHLORIDE |
| Padagis US LLC | loteprednol etabonate | 0574-4080 | EDETATE DISODIUM |
| Padagis US LLC | loteprednol etabonate | 0574-4080 | GLYCERIN |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for loteprednol etabonate
Excipient focus: BENZALKONIUM CHLORIDE
loteprednol etabonate drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| Physicians Total Care Inc | loteprednol etabonate | 54868-4278 |
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: BORIC ACID
loteprednol etabonate drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | loteprednol etabonate | 17478-830 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-503 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
loteprednol etabonate drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
loteprednol etabonate drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
loteprednol etabonate drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
loteprednol etabonate drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | loteprednol etabonate | 17478-830 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-503 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
loteprednol etabonate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
loteprednol etabonate drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
loteprednol etabonate drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
loteprednol etabonate drug variants containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POLOXAMER 407
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYCARBOPHIL
loteprednol etabonate drug variants containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | loteprednol etabonate | 17478-830 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-503 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POLYCARBOPHIL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
loteprednol etabonate drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-299 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-353 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| Akorn | loteprednol etabonate | 17478-830 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
loteprednol etabonate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| Akorn | loteprednol etabonate | 50383-265 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| Akorn | loteprednol etabonate | 17478-830 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-299 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
loteprednol etabonate drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | loteprednol etabonate | 60219-1366 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
loteprednol etabonate drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | loteprednol etabonate | 17478-830 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-503 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
loteprednol etabonate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | loteprednol etabonate | 17478-830 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-503 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
loteprednol etabonate drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: SULFURIC ACID
loteprednol etabonate drug variants containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate and tobramycin | 24208-358 |
| Alembic Pharmaceuticals Limited | loteprednol etabonate and tobramycin | 46708-801 |
| Alembic Pharmaceuticals Inc | loteprednol etabonate and tobramycin | 62332-801 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing SULFURIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
loteprednol etabonate drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
loteprednol etabonate drug variants containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-507 |
| ALCON LABORATORIES INC | loteprednol etabonate | 71571-121 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
loteprednol etabonate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | loteprednol etabonate | 0574-4080 |
| Padagis US LLC | loteprednol etabonate | 0574-4135 |
| STAT Rx USA LLC | loteprednol etabonate | 16590-007 |
| >Company | >Ingredient | >NDC |
loteprednol etabonate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | loteprednol etabonate | 24208-443 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
